Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Gilead Sciences (NQ: GILD)
67.00 USD  -0.35 (-0.52%)
Official Closing Price  /  Updated: 7:54 PM EST, Feb 20, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 8,697,100
Open 67.26
Bid (Size) 66.75 (2)
Ask (Size) 66.88 (7)
Prev. Close 67.35
Today's Range 66.10 - 67.36
52wk Range 60.89 - 71.19
Shares Outstanding 1,300,260,832
Dividend Yield 3.33%
Performance
YTD
+2.71%
+2.71%
1 Month
+6.98%
+6.98%
3 Month
+1.93%
+1.93%
6 Month
+4.33%
+4.33%
1 Year
+0.03%
+0.03%
Top News
More News
Gilead Appoints Michael Quigley to Lead Research Biology Group and Names Linda Higgins as Head of Company’s External Innovation Center
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Michael Quigley, PhD has joined the company as Senior Vice President, Research Biology, bringing to the role deep experience in oncology and... Read More
from Business Wire News Releases
Gilead Sciences to Present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Johanna Mercier, Chief Commercial Officer, and Merdad Parsey, MD, PhD, Chief Medical Officer, will participate in a fireside chat at the Cowen... Read More
from Business Wire News Releases
More News
Read More
UPDATE 3-WHO says no time for complacency as China coronavirus cases fall
category companyNews
from Reuters: Company News
Notable Thursday Option Activity: STX, UNP, GILD
category Stocks
from Market News Video
UPDATE 2-WHO says no time for complacency as China coronavirus cases fall
category companyNews
from Reuters: Company News
Where Will Gilead Sciences Be in 10 Years?
category GLPG , JNJ , Market News , and 4 more.
from Motley Fool
Report: Gilead Struggling to Find Subjects for COVID-19 Drug Trial
category GILD , Market News
from Motley Fool
Johnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19
category GILD , Market News , JNJ
from Motley Fool
2 Reasons to Be Optimistic About Gilead Sciences’ Future
category Market News , GILD , GLPG
from Motley Fool
Is Viking Therapeutics' Stock a Buy?
category LLY , GS , Market News , and 5 more.
from Motley Fool
Your Dirty Dozen
category Stocks / Equities , Options , Bonds
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.